204 related articles for article (PubMed ID: 26200748)
1. Cellular uptake, cytotoxicity and in-vivo evaluation of Tamoxifen citrate loaded niosomes.
Shaker DS; Shaker MA; Hanafy MS
Int J Pharm; 2015 Sep; 493(1-2):285-94. PubMed ID: 26200748
[TBL] [Abstract][Full Text] [Related]
2. Evaluation and optimization of pH-responsive niosomes as a carrier for efficient treatment of breast cancer.
Salem HF; Kharshoum RM; Abo El-Ela FI; F AG; Abdellatif KRA
Drug Deliv Transl Res; 2018 Jun; 8(3):633-644. PubMed ID: 29488171
[TBL] [Abstract][Full Text] [Related]
3. Topotecan-tamoxifen duple PLGA polymeric nanoparticles: investigation of in vitro, in vivo and cellular uptake potential.
Khuroo T; Verma D; Talegaonkar S; Padhi S; Panda AK; Iqbal Z
Int J Pharm; 2014 Oct; 473(1-2):384-94. PubMed ID: 25051112
[TBL] [Abstract][Full Text] [Related]
4. Effective cellular internalization, cell cycle arrest and improved pharmacokinetics of Tamoxifen by cholesterol based lipopolymeric nanoparticles.
Mazumdar S; Italiya KS; Sharma S; Chitkara D; Mittal A
Int J Pharm; 2018 May; 543(1-2):96-106. PubMed ID: 29578081
[TBL] [Abstract][Full Text] [Related]
5. Enhancing the Therapeutic Efficacy of Tamoxifen Citrate Loaded Span-Based Nano-Vesicles on Human Breast Adenocarcinoma Cells.
Kassem MA; Megahed MA; Abu Elyazid SK; Abd-Allah FI; Abdelghany TM; Al-Abd AM; El-Say KM
AAPS PharmSciTech; 2018 May; 19(4):1529-1543. PubMed ID: 29470829
[TBL] [Abstract][Full Text] [Related]
6. Application of Box-Behnken Design in the Preparation, Optimization, and In Vitro Evaluation of Self-Assembly-Based Tamoxifen- and Doxorubicin-Loaded and Dual Drug-Loaded Niosomes for Combinatorial Breast Cancer Treatment.
Kulkarni P; Rawtani D
J Pharm Sci; 2019 Aug; 108(8):2643-2653. PubMed ID: 30905701
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen citrate loaded chitosan-gellan nanocapsules for breast cancer therapy: development, characterisation and in-vitro cell viability study.
Kathle PK; Gautam N; Kesavan K
J Microencapsul; 2018 May; 35(3):292-300. PubMed ID: 29771175
[TBL] [Abstract][Full Text] [Related]
8. In vitro cytotoxicity and bioavailability of solid lipid nanoparticles containing tamoxifen citrate.
Hashem FM; Nasr M; Khairy A
Pharm Dev Technol; 2014 Nov; 19(7):824-32. PubMed ID: 24032414
[TBL] [Abstract][Full Text] [Related]
9. Single-walled carbon nanotubes mediated targeted tamoxifen delivery system using aspargine-glycine-arginine peptide.
Chen C; Hou L; Zhang H; Zhu L; Zhang H; Zhang C; Shi J; Wang L; Jia X; Zhang Z
J Drug Target; 2013 Nov; 21(9):809-21. PubMed ID: 24024582
[TBL] [Abstract][Full Text] [Related]
10.
Hajizadeh MR; Maleki H; Barani M; Fahmidehkar MA; Mahmoodi M; Torkzadeh-Mahani M
Res Pharm Sci; 2019 Oct; 14(5):448-458. PubMed ID: 31798662
[TBL] [Abstract][Full Text] [Related]
11. Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer.
Zalba S; Contreras AM; Haeri A; Ten Hagen TL; Navarro I; Koning G; Garrido MJ
J Control Release; 2015 Jul; 210():26-38. PubMed ID: 25998052
[TBL] [Abstract][Full Text] [Related]
12. In Vitro Cytotoxicity and Cellular Uptake of Tamoxifen Citrate-Loaded Polymeric Micelles.
Nasr M; Hashem F; Abdelmoniem R; Tantawy N; Teiama M
AAPS PharmSciTech; 2020 Nov; 21(8):306. PubMed ID: 33151433
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen-loaded nanostructured lipid carrier as a drug delivery system: characterization, stability assessment and cytotoxicity.
How CW; Rasedee A; Manickam S; Rosli R
Colloids Surf B Biointerfaces; 2013 Dec; 112():393-9. PubMed ID: 24036474
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen citrate-loaded poly(d,l) lactic acid nanoparticles: Evaluation for their anticancer activity in vitro and in vivo.
Ravikumara NR; Bharadwaj M; Madhusudhan B
J Biomater Appl; 2016 Nov; 31(5):755-772. PubMed ID: 27664187
[TBL] [Abstract][Full Text] [Related]
15. Treatment of breast cancer with engineered novel pH-sensitive triaryl-(Z)-olefin niosomes containing hydrogel: an
Salem HF; Kharshoum RM; Gamal F A; Abo El-Ela FI; Abdellatif KRA
J Liposome Res; 2020 Jun; 30(2):126-135. PubMed ID: 30935273
[TBL] [Abstract][Full Text] [Related]
16. The liposomal daunorubicin plus tamoxifen: improving the stability, uptake, and biodistribution of carriers.
Shao M; Sun SL; Li MH; Li BX; Yu H; Shen ZY; Ren YC; Hao ZF; Chang ND; Peng HS; Yang BF
J Liposome Res; 2012 Jun; 22(2):168-76. PubMed ID: 22428938
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells.
Ko JC; Chiu HC; Syu JJ; Jian YJ; Chen CY; Jian YT; Huang YJ; Wo TY; Lin YW
Biochem Pharmacol; 2014 Mar; 88(1):119-27. PubMed ID: 24447935
[TBL] [Abstract][Full Text] [Related]
18. The influence of phospholipid on the physicochemical properties and anti-tumor efficacy of liposomes encapsulating cisplatin in mice bearing C26 colon carcinoma.
Alavizadeh SH; Badiee A; Golmohammadzadeh S; Jaafari MR
Int J Pharm; 2014 Oct; 473(1-2):326-33. PubMed ID: 25051111
[TBL] [Abstract][Full Text] [Related]
19. Reduction of tamoxifen resistance in human breast carcinomas by tamoxifen-containing liposomes in vivo.
Zeisig R; Rückerl D; Fichtner I
Anticancer Drugs; 2004 Aug; 15(7):707-14. PubMed ID: 15269602
[TBL] [Abstract][Full Text] [Related]
20. Enhanced anticancer effect and reduced toxicity of doxorubicin in combination with thymoquinone released from poly-N-acetyl glucosamine nanomatrix in mice bearing solid Ehrlish carcinoma.
El-Ashmawy NE; Khedr EG; Ebeid EM; Salem ML; Zidan AA; Mosalam EM
Eur J Pharm Sci; 2017 Nov; 109():525-532. PubMed ID: 28890201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
